-
Something wrong with this record ?
Limited effect of adaptive immune response to control encephalitozoonosis
B. Sak, M. Kotková, L. Hlásková, M. Kváč,
Language English Country Great Britain
Document type Journal Article
NLK
Free Medical Journals
from 1997 to 1 year ago
Medline Complete (EBSCOhost)
from 1998-01-01 to 1 year ago
Wiley Free Content
from 1997 to 1 year ago
PubMed
29032596
DOI
10.1111/pim.12496
Knihovny.cz E-resources
- MeSH
- Adaptive Immunity immunology MeSH
- Albendazole therapeutic use MeSH
- Anthelmintics therapeutic use MeSH
- Immunity, Cellular immunology MeSH
- CD4-Positive T-Lymphocytes immunology MeSH
- CD8-Positive T-Lymphocytes immunology MeSH
- Encephalitozoon cuniculi growth & development immunology MeSH
- Encephalitozoonosis immunology microbiology MeSH
- Lymphopenia immunology MeSH
- Mice, Inbred C57BL MeSH
- Mice, Knockout MeSH
- Mice MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
This study revises our understanding of the effectiveness of cell-mediated adaptive immunity and treatment against microsporidia using molecular detection and quantification of microsporidia in immunocompetent C57Bl/6 and immunodeficient CD4-/-and CD8-/-mice for the first time. We demonstrate an intense dissemination of microsporidia into most organs within the first weeks post-infection in all strains of mice, followed by a chronic infection characterized by microsporidia persistence in CD4-/-and C57Bl/6 mice and a lethal outcome for CD8-/-mice. Albendazole application reduces microsporidia burden in C57Bl/6 and CD4-/-mice, whereas CD8-/-mice experience only a temporary effect of the treatment. Surprisingly, treated CD8-/-mice survived the entire experimental duration despite enormous microsporidia burden. On the basis of our results, we conclude that microsporidia survive despite the presence of immune mechanisms and treatments that are currently considered to be effective and therefore that CD8 T lymphocytes represent a major, but not sole effector mechanism controlling microsporidiosis. Furthermore, the survival of mice does not correspond to spore burden, which provides new insight into latent microsporidiosis from an epidemiological point of view.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18010302
- 003
- CZ-PrNML
- 005
- 20180417111114.0
- 007
- ta
- 008
- 180404s2017 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/pim.12496 $2 doi
- 035 __
- $a (PubMed)29032596
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Sak, B $u Institute of Parasitology, BC CAS, v.v.i., České Budějovice, Czech Republic.
- 245 10
- $a Limited effect of adaptive immune response to control encephalitozoonosis / $c B. Sak, M. Kotková, L. Hlásková, M. Kváč,
- 520 9_
- $a This study revises our understanding of the effectiveness of cell-mediated adaptive immunity and treatment against microsporidia using molecular detection and quantification of microsporidia in immunocompetent C57Bl/6 and immunodeficient CD4-/-and CD8-/-mice for the first time. We demonstrate an intense dissemination of microsporidia into most organs within the first weeks post-infection in all strains of mice, followed by a chronic infection characterized by microsporidia persistence in CD4-/-and C57Bl/6 mice and a lethal outcome for CD8-/-mice. Albendazole application reduces microsporidia burden in C57Bl/6 and CD4-/-mice, whereas CD8-/-mice experience only a temporary effect of the treatment. Surprisingly, treated CD8-/-mice survived the entire experimental duration despite enormous microsporidia burden. On the basis of our results, we conclude that microsporidia survive despite the presence of immune mechanisms and treatments that are currently considered to be effective and therefore that CD8 T lymphocytes represent a major, but not sole effector mechanism controlling microsporidiosis. Furthermore, the survival of mice does not correspond to spore burden, which provides new insight into latent microsporidiosis from an epidemiological point of view.
- 650 _2
- $a adaptivní imunita $x imunologie $7 D056704
- 650 _2
- $a albendazol $x terapeutické užití $7 D015766
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a anthelmintika $x terapeutické užití $7 D000871
- 650 _2
- $a CD4-pozitivní T-lymfocyty $x imunologie $7 D015496
- 650 _2
- $a CD8-pozitivní T-lymfocyty $x imunologie $7 D018414
- 650 _2
- $a Encephalitozoon cuniculi $x růst a vývoj $x imunologie $7 D009670
- 650 _2
- $a encephalitozoonóza $x imunologie $x mikrobiologie $7 D016890
- 650 _2
- $a buněčná imunita $x imunologie $7 D007111
- 650 _2
- $a lymfopenie $x imunologie $7 D008231
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a myši knockoutované $7 D018345
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kotková, M $u Faculty of Agriculture, University of South Bohemia in České Budějovice, České Budějovice, Czech Republic.
- 700 1_
- $a Hlásková, L $u Institute of Parasitology, BC CAS, v.v.i., České Budějovice, Czech Republic.
- 700 1_
- $a Kváč, M $u Institute of Parasitology, BC CAS, v.v.i., České Budějovice, Czech Republic. Faculty of Agriculture, University of South Bohemia in České Budějovice, České Budějovice, Czech Republic.
- 773 0_
- $w MED00003687 $t Parasite immunology $x 1365-3024 $g Roč. 39, č. 12 (2017)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29032596 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180417111213 $b ABA008
- 999 __
- $a ok $b bmc $g 1287787 $s 1007114
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 39 $c 12 $e 20171101 $i 1365-3024 $m Parasite immunology $n Parasite Immunol $x MED00003687
- LZP __
- $a Pubmed-20180404